Addenda Capital Lowered By $344,228 Its Unitedhealth Group (UNH) Position; Profile of 0 Analysts Covering Kronos Worldwide, Inc. (KRO)

Among 2 analysts covering Kronos Worldwide (NYSE:KRO), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Kronos Worldwide had 4 analyst reports since August 19, 2015 according to SRatingsIntel. Barclays Capital maintained the shares of KRO in report on Tuesday, November 14 with “Underweight” rating. The company was maintained on Thursday, August 10 by Barclays Capital. See Kronos Worldwide, Inc. (NYSE:KRO) latest ratings:

14/11/2017 Broker: Barclays Capital Rating: Underweight Old Target: $17 New Target: $24 Maintain

Addenda Capital Inc decreased Unitedhealth Group Inc (UNH) stake by 5.17% reported in 2017Q3 SEC filing. Addenda Capital Inc sold 1,831 shares as Unitedhealth Group Inc (UNH)’s stock rose 9.50%. The Addenda Capital Inc holds 33,609 shares with $6.34 million value, down from 35,440 last quarter. Unitedhealth Group Inc now has $218.14B valuation. The stock increased 0.31% or $0.7 during the last trading session, reaching $225.43. About 4.83M shares traded or 31.76% up from the average. UnitedHealth Group Incorporated (NYSE:UNH) has risen 32.76% since March 12, 2017 and is uptrending. It has outperformed by 16.06% the S&P500.

Since September 15, 2017, it had 0 insider buys, and 9 insider sales for $28.70 million activity. BURKE RICHARD T sold $4.79 million worth of stock or 20,000 shares. RENFRO LARRY C sold $10.02M worth of stock. 975 UnitedHealth Group Incorporated (NYSE:UNH) shares with value of $200,333 were sold by ROOS THOMAS E. The insider BALLARD WILLIAM C JR sold 10,000 shares worth $2.46M. HOOPER MICHELE J also sold $2.38M worth of UnitedHealth Group Incorporated (NYSE:UNH) shares. 198 UnitedHealth Group Incorporated (NYSE:UNH) shares with value of $48,025 were sold by Shine Kenneth Irwin. 5,820 UnitedHealth Group Incorporated (NYSE:UNH) shares with value of $1.40M were sold by WILENSKY GAIL R.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.05, from 0.91 in 2017Q2. It is positive, as 46 investors sold UNH shares while 524 reduced holdings. 112 funds opened positions while 408 raised stakes. 810.94 million shares or 0.66% less from 816.36 million shares in 2017Q2 were reported. Kemnay Advisory Svcs invested in 4,196 shares or 0.35% of the stock. Whitnell And reported 394 shares. Woodmont Invest Counsel Llc has invested 0.81% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Cambridge Trust Company owns 151,413 shares. Monetta Fincl has invested 2.87% in UnitedHealth Group Incorporated (NYSE:UNH). Orbimed Advsrs Ltd Limited Liability Company owns 380,000 shares or 0.71% of their US portfolio. Banque Pictet Cie Sa owns 190,943 shares for 0.85% of their portfolio. Parkwood Ltd Llc stated it has 21,851 shares or 0.64% of all its holdings. Washington invested in 1,481 shares. Jensen Investment Management invested in 4.39% or 1.66M shares. Stratos Wealth Prtn has 0.15% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 16,349 shares. Atika Capital Mgmt Ltd Liability Co, New York-based fund reported 18,000 shares. Spark Management Ltd Liability owns 34,200 shares. Northeast Fin Consultants accumulated 5,465 shares or 0.39% of the stock. 1832 Asset Mgmt Lp holds 662,548 shares.

Among 26 analysts covering UnitedHealth Group (NYSE:UNH), 26 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. UnitedHealth Group has $280.0 highest and $124 lowest target. $218.91’s average target is -2.89% below currents $225.43 stock price. UnitedHealth Group had 81 analyst reports since September 2, 2015 according to SRatingsIntel. On Wednesday, November 30 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was maintained by Cowen & Co with “Buy” on Friday, August 11. The stock of UnitedHealth Group Incorporated (NYSE:UNH) has “Buy” rating given on Friday, November 20 by Mizuho. The company was maintained on Thursday, November 16 by Cantor Fitzgerald. The firm has “Buy” rating given on Wednesday, October 18 by Citigroup. The stock of UnitedHealth Group Incorporated (NYSE:UNH) has “Buy” rating given on Tuesday, June 27 by Stifel Nicolaus. The stock of UnitedHealth Group Incorporated (NYSE:UNH) earned “Overweight” rating by Morgan Stanley on Thursday, August 17. The firm earned “Buy” rating on Wednesday, December 7 by Cantor Fitzgerald. Cantor Fitzgerald maintained it with “Buy” rating and $208.0 target in Wednesday, August 16 report. Mizuho downgraded the stock to “Neutral” rating in Wednesday, November 9 report.

Addenda Capital Inc increased Enbridge Inc (NYSE:ENB) stake by 31,770 shares to 1.59M valued at $66.39M in 2017Q3. It also upped Stantec Inc (NYSE:STN) stake by 188,920 shares and now owns 559,221 shares. Suncor Energy Inc New (NYSE:SU) was raised too.

Analysts await UnitedHealth Group Incorporated (NYSE:UNH) to report earnings on April, 17. They expect $2.92 EPS, up 23.21% or $0.55 from last year’s $2.37 per share. UNH’s profit will be $2.83 billion for 19.30 P/E if the $2.92 EPS becomes a reality. After $2.59 actual EPS reported by UnitedHealth Group Incorporated for the previous quarter, Wall Street now forecasts 12.74% EPS growth.

Investors sentiment increased to 1.46 in 2017 Q3. Its up 0.06, from 1.4 in 2017Q2. It improved, as 24 investors sold Kronos Worldwide, Inc. shares while 28 reduced holdings. 33 funds opened positions while 40 raised stakes. 18.48 million shares or 10.74% more from 16.69 million shares in 2017Q2 were reported. Virginia Retirement Sys Et Al holds 34,500 shares. Ahl Prtnrs Limited Liability Partnership reported 407,733 shares stake. 23,900 are owned by Lingohr & Partner Asset Mngmt Gmbh. Macquarie Grp Incorporated Ltd holds 5,000 shares. Navellier & Assocs Inc has 0.2% invested in Kronos Worldwide, Inc. (NYSE:KRO) for 45,098 shares. The New York-based Gotham Asset Ltd Co has invested 0.03% in Kronos Worldwide, Inc. (NYSE:KRO). Walleye Trading Limited Liability accumulated 4,954 shares. State Street Corp has invested 0% in Kronos Worldwide, Inc. (NYSE:KRO). Aqr Mngmt Limited Liability Co has 0.02% invested in Kronos Worldwide, Inc. (NYSE:KRO). New York-based Citigroup has invested 0% in Kronos Worldwide, Inc. (NYSE:KRO). Moreover, Geode Mngmt Limited Liability Company has 0% invested in Kronos Worldwide, Inc. (NYSE:KRO) for 446,237 shares. Morgan Stanley, a New York-based fund reported 132,721 shares. Hbk Invs L P holds 14,100 shares. Ny State Common Retirement Fund has invested 0% in Kronos Worldwide, Inc. (NYSE:KRO). Envestnet Asset Mngmt owns 2 shares for 0% of their portfolio.

The stock increased 3.15% or $0.73 during the last trading session, reaching $23.88. About 326,190 shares traded. Kronos Worldwide, Inc. (NYSE:KRO) has risen 245.94% since March 12, 2017 and is uptrending. It has outperformed by 229.24% the S&P500.

Kronos Worldwide, Inc. produces and markets titanium dioxide pigments in Europe, North America, the Asia Pacific, and internationally. The company has market cap of $2.77 billion. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, such as paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, food, and cosmetics. It has a 8.38 P/E ratio. The firm also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; titanium oxychloride for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices; and titanyl sulfate that is used in pearlescent pigments, natural gas pipe, and other specialty applications.